495 related articles for article (PubMed ID: 9104811)
1. Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model.
Ehl S; Hombach J; Aichele P; Hengartner H; Zinkernagel RM
J Exp Med; 1997 Apr; 185(7):1241-51. PubMed ID: 9104811
[TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
[TBL] [Abstract][Full Text] [Related]
3. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
Oxenius A; Bachmann MF; Zinkernagel RM; Hengartner H
Eur J Immunol; 1998 Jan; 28(1):390-400. PubMed ID: 9485218
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences.
Zimmermann C; Prévost-Blondel A; Blaser C; Pircher H
Eur J Immunol; 1999 Jan; 29(1):284-90. PubMed ID: 9933110
[TBL] [Abstract][Full Text] [Related]
5. Limited in vivo reactivity of polyclonal effector cytotoxic T cells towards altered peptide ligands.
Bättig P; Saudan P; Storni T; Gallimore A; Bachmann MF
Microbes Infect; 2005 Apr; 7(4):729-37. PubMed ID: 15857805
[TBL] [Abstract][Full Text] [Related]
6. Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes.
Slifka MK; Shen H; Matloubian M; Jensen ER; Miller JF; Ahmed R
J Virol; 1996 May; 70(5):2902-10. PubMed ID: 8627765
[TBL] [Abstract][Full Text] [Related]
7. Naive CD8+ T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells.
Wang B; Maile R; Greenwood R; Collins EJ; Frelinger JA
J Immunol; 2000 Feb; 164(3):1216-22. PubMed ID: 10640733
[TBL] [Abstract][Full Text] [Related]
8. Virus-induced polyclonal cytotoxic T lymphocyte stimulation.
Yang HY; Dundon PL; Nahill SR; Welsh RM
J Immunol; 1989 Mar; 142(5):1710-8. PubMed ID: 2537363
[TBL] [Abstract][Full Text] [Related]
9. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
Nahill SR; Welsh RM
J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
[TBL] [Abstract][Full Text] [Related]
10. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
[TBL] [Abstract][Full Text] [Related]
11. Restricted V-segment usage in T-cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus.
Yanagi Y; Maekawa R; Cook T; Kanagawa O; Oldstone MB
J Virol; 1990 Dec; 64(12):5919-26. PubMed ID: 1700830
[TBL] [Abstract][Full Text] [Related]
12. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.
Selin LK; Nahill SR; Welsh RM
J Exp Med; 1994 Jun; 179(6):1933-43. PubMed ID: 8195718
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells efficiently induce protective antiviral immunity.
Ludewig B; Ehl S; Karrer U; Odermatt B; Hengartner H; Zinkernagel RM
J Virol; 1998 May; 72(5):3812-8. PubMed ID: 9557664
[TBL] [Abstract][Full Text] [Related]
14. Suppression of virus-specific antibody production by CD8+ class I-restricted antiviral cytotoxic T cells in vivo.
Moskophidis D; Pircher H; Ciernik I; Odermatt B; Hengartner H; Zinkernagel RM
J Virol; 1992 Jun; 66(6):3661-8. PubMed ID: 1583725
[TBL] [Abstract][Full Text] [Related]
15. Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens.
Lenz LL; Butz EA; Bevan MJ
J Exp Med; 2000 Oct; 192(8):1135-42. PubMed ID: 11034603
[TBL] [Abstract][Full Text] [Related]
16. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
[TBL] [Abstract][Full Text] [Related]
17. Consequences of cytotoxic T lymphocyte interaction with major histocompatibility complex class I-expressing neurons in vivo.
Rall GF; Mucke L; Oldstone MB
J Exp Med; 1995 Nov; 182(5):1201-12. PubMed ID: 7595191
[TBL] [Abstract][Full Text] [Related]
18. FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory.
Pinschewer DD; Ochsenbein AF; Odermatt B; Brinkmann V; Hengartner H; Zinkernagel RM
J Immunol; 2000 Jun; 164(11):5761-70. PubMed ID: 10820254
[TBL] [Abstract][Full Text] [Related]
19. Virus-induced activation of self-specific TCR alpha beta CD8 alpha alpha intraepithelial lymphocytes does not abolish their self-tolerance in the intestine.
Saurer L; Seibold I; Rihs S; Vallan C; Dumrese T; Mueller C
J Immunol; 2004 Apr; 172(7):4176-83. PubMed ID: 15034030
[TBL] [Abstract][Full Text] [Related]
20. Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen.
Oehen S; Waldner H; Kündig TM; Hengartner H; Zinkernagel RM
J Exp Med; 1992 Nov; 176(5):1273-81. PubMed ID: 1402673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]